about
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pul...
Read More
28.63
0.33
(1.17%)
195.7K
XNAS Volume
XNAS 20 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Avalyn Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..